| ACE-R | Addenbrooke’s Cognitive Examination-Revised |
| AD | Alzheimer’s Disease |
| ADNI | Alzheimer’s Disease Neuroimaging Initiative |
| APOE | Apolipoprotein E |
| CBS | Cambridge Brain Sciences |
| CES-D | Centre for Epidemiological Studies Depression Scale |
| CSN | Canadian Stroke Network |
| DTI | Diffusion Tensor Imaging |
| DWI | Diffusion-Weighted Imaging |
| Extended-CATCH | CT and MRI in the Triage of TIA and minor Cerebrovascular events to identify High-risk patients |
| GTP-RAB5 | Guanine trinucleotide-bound Ras-Related Protein in Brain 5 |
| IQCODE | Informant Questionnaire on Cognitive Decline in the Elderly |
| MCI | Mild Cognitive Impairment |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| MRI | Magnetic Resonance Imaging |
| MTA | Mesial Temporal Atrophy |
| NIHSS | National Institutes of Health Stroke Scale |
| NINDS | National Institute of Neurological Disorders and Stroke |
| OXVASC | Oxford Vascular Study |
| PET | Positron Emission Tomography |
| PREVENT | Predementia Neuroimaging of Transient Ischemic Attack |
| RIN3 | Ras And Rab Interactor 3 |
| STROKOG | Stroke and Cognition consortium |
| SVD | Small Vessel Disease |
| TCI | Transient cognitive impairment |
| TIA | Transient Ischemic Attack |
| TICSm | Telephone Interview of Cognitive Status |
| T-MoCA | Telephone Montreal Cognitive Assessment |
| TMT-B | Trail Making Test-B |
| VCI | Vascular Cognitive Impairment |
| WMH | White Matter Hyperintensities |